Fever with Altered sensorium etiology evaluation and management

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

fever altered sensorium etiology management

Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Searching Images

fever altered consciousness differential diagnosis approach flowchart

I now have comprehensive material from Plum & Posner, Harrison's, Tintinalli's, and Miller's Anesthesia. Let me compile the full, authoritative response.

Fever with Altered Sensorium: Etiology, Evaluation, and Management

Fever combined with altered sensorium is one of the most urgent clinical presentations in emergency medicine. It signals potential failure of the brain as either a direct target of infection/inflammation or as a bystander of systemic metabolic derangement. The brain tolerates only limited metabolic or structural injury, and delays in treatment measurably worsen outcomes - for bacterial meningitis, the odds of an unfavorable outcome may increase by 30% for each hour treatment is delayed.

1. Understanding the Core Terms

Before approaching etiology, it helps to define the spectrum of altered sensorium (from Plum and Posner's Diagnosis and Treatment of Stupor and Coma):
TermMeaning
CloudingMinimal reduction in wakefulness; irritability alternating with drowsiness
DeliriumAcute disturbance of attention, awareness, cognition; fluctuating; hours to days
ObtundationReduced alertness with slowed psychomotor responses
StuporArousable only by vigorous stimuli; returns to unresponsiveness
ComaUnarousable unresponsiveness
Delirium is defined by DSM-5 as an acute disturbance of attention and awareness, fluctuating in severity, with additional cognitive disturbance that is a direct physiological consequence of a medical condition.

2. Pathophysiological Framework: Two Major Categories

The causes of fever with altered sensorium divide into two broad mechanistic categories:

A. Structural Causes (direct anatomical injury)

  • Supratentorial (cerebral hemispheres, thalamus, basal ganglia)
  • Subtentorial (brainstem, cerebellum)

B. Metabolic / Diffuse Encephalopathic Causes

  • Infection involving the brain (meningoencephalitis, cerebritis, abscess)
  • Systemic infection causing secondary brain dysfunction (septic encephalopathy)
  • Toxic, drug-related, or metabolic derangements
In the classic series of 500 patients with coma of unknown etiology from Plum and Posner's, diffuse and metabolic causes accounted for 326/500 (65%) - the single largest category, with structural lesions making up the rest.

3. Etiological Classification (Fever + Altered Sensorium)

3A. Infectious Causes (Most Common in Fever Context)

CNS Infections

ConditionKey Features
Bacterial meningitisFever, meningismus, altered mental status - classic triad in only 1/3 to 1/2 of adults; S. pneumoniae (30-60%), N. meningitidis (10-35%); Listeria in elderly/immunocompromised
Viral encephalitisTriad of headache, fever, altered mental status; behavioral changes, new psychiatric symptoms, seizures; HSV accounts for 40-50% of identified cases
Brain abscessFever, headache, focal neurologic signs; often NO systemic signs; develops over ~14 days from focal cerebritis to encapsulated pus
Subdural empyema60-70% from paranasal sinuses; fever, headache, nuchal rigidity; 75% have focal signs; 6-20% mortality
Septic cavernous sinus thrombosisFacial/sphenoid sinus source; periorbital edema → proptosis, ophthalmoplegia; 70% staphylococci
Cerebral malariaTravelers from endemic regions; fever + coma + seizures; must rule out urgently
Tuberculous meningitisSubacute onset; basal meningitis; cranial nerve palsies; high protein, low glucose CSF
Cryptococcal meningitisInsidious in immunocompromised; India ink positive; elevated opening pressure
NeurocysticercosisSeizures as first presentation; Latin American exposure history

Regional/Travel-Specific Pathogens (per Tintinalli's):

  • Cerebral malaria - any malarial endemic region
  • Japanese encephalitis / West Nile encephalitis - arboviral; summer; mosquito-borne
  • Typhoid fever - Salmonella typhi; rose spots, splenomegaly, constipation/diarrhea
  • Rickettsial infections - tick bite; rash; Rocky Mountain spotted fever
  • Rabies - animal bite history; hydrophobia, pharyngeal spasm
  • Human African trypanosomiasis (sleeping sickness) - sub-Saharan Africa; CNS invasion in late stage
  • Dengue - severe dengue with neurologic involvement

Systemic Infections with CNS Dysfunction

  • Sepsis-associated encephalopathy - SIRS + fever + confusion without primary CNS infection; most common cause of altered sensorium in ICU patients
  • Septic shock - hypotension, end-organ dysfunction contributing to cerebral hypoperfusion

3B. Non-Infectious Causes (must exclude)

CategoryExamples
Drugs/ToxinsDrug overdose (anticholinergics, opioids, benzodiazepines, TCAs); drug withdrawal (alcohol, benzodiazepines); serotonin syndrome; neuroleptic malignant syndrome (NMS)
MetabolicHypoglycemia, hyperglycemia, hyponatremia, hyperammonemia (hepatic encephalopathy), uremia, thyroid storm, adrenal crisis
Autoimmune encephalitisAnti-NMDA receptor encephalitis; limbic encephalitis; fever + psychiatric symptoms + movement abnormalities + autonomic instability
Structural + FeverIntracranial hemorrhage (fever from central cause); brain tumor with fever (necrosis, secondary infection)
Heat strokeCore temperature >40°C, anhidrosis, altered mental status; a diagnosis of exclusion
Status epilepticusProlonged seizures cause fever + coma (post-ictal state + hyperthermia)
ParaneoplasticLimbic encephalitis; subacute onset

4. Evaluation: Systematic Approach

Step 1 - Stabilize First (ABC + Vital Signs)

Before any diagnostic workup:
  • Airway - protect if GCS ≤8 or rapidly declining
  • Breathing - supplemental O2, monitor SpO2
  • Circulation - IV access, fluid resuscitation if hypotensive
  • Glucose - immediate fingerstick (treat hypoglycemia with IV dextrose before waiting for labs)
  • Temperature - document core temp; >41°C suggests heat stroke or NMS
  • Naloxone - consider empirically if opioid toxidrome suspected

Step 2 - Targeted History (from family/witnesses)

Key questions:
  • Onset - sudden (hemorrhage, seizure) vs. subacute (meningitis, abscess, autoimmune) vs. insidious (TBM, fungal, paraneoplastic)
  • Travel history - malaria-endemic area, tropical exposures
  • Animal contact - rabies risk
  • Immunocompromised state - HIV, transplant, steroids, chemotherapy
  • Drug use - recreational drugs, prescription medications, withdrawals
  • Preceding illness - viral prodrome (post-infectious ADEM), ear/sinus infection (abscess, empyema)
  • Seizures - witnessed convulsions
  • Rash - meningococcemia (petechiae/purpura), rickettsial disease, HSV vesicles, typhoid rose spots

Step 3 - Physical Examination

FindingSuggests
Nuchal rigidity + Kernig's/Brudzinski'sMeningitis / SAH
Petechial/purpuric rashMeningococcemia (N. meningitidis)
Focal neurologic signs + papilledemaMass lesion (abscess, empyema, tumor)
Periorbital edema, proptosisCavernous sinus thrombosis
Vesicular rashHSV / VZV encephalitis
Lymphadenopathy + splenomegalyEBV, HIV, trypanosomiasis
Hydrophobia, pharyngeal spasmRabies
Choreoathetosis, parkinsonian signsArboviral encephalitis (basal ganglia tropism)
Temporal lobe signs (aphasia, memory)HSV encephalitis (limbic predilection)
Autonomic instability + hyperthermiaNMS, serotonin syndrome
Jaundice + asterixisHepatic encephalopathy
ParotitisMumps encephalitis

Step 4 - Investigations

Immediate (within minutes):
  • Blood glucose (bedside)
  • CBC, CMP (electrolytes, renal/liver function), coagulation
  • Blood cultures x2 (before antibiotics if possible, but never delay empiric treatment)
  • Blood smear for malaria (travelers from endemic areas)
  • ABG / lactate
Urgent Imaging:
  • CT head without contrast - before LP if papilledema, focal neurologic signs, immunocompromised state, or new seizures are present (to rule out mass effect / herniation risk)
  • MRI brain with contrast - preferred over CT; more sensitive for encephalitis (HSV: medial temporal + inferior frontal lobe hyperintensity on FLAIR), abscess, demyelination, venous sinus thrombosis
Lumbar Puncture (CSF Analysis):
LP is the cornerstone test - should not be delayed if no contraindication:
ParameterBacterial MeningitisViral EncephalitisTBMFungal (Crypto)
Opening pressure↑↑Normal/↑↑↑↑
AppearanceTurbidClearClear/xanthochromicClear
WBC>1000, PMN predominant10-500, lymphocytic100-500, lymphocytic20-500, lymphocytic
Protein↑↑ (>1 g/L)Mildly ↑↑↑ (>1 g/L)
Glucose↓↓ (<40 mg/dL)Normal
Special testsGram stain, culturePCR (HSV, EBV, CMV, enteroviruses)AFB smear/culture, ADAIndia ink, CrAg
  • Also send: CSF VDRL (syphilis), cytology (malignant meningitis), autoimmune panel (anti-NMDA, LGI1, CASPR2, AMPA, GABA-B receptors)
  • EEG - if subclinical seizures or status epilepticus suspected; also helpful in HSV encephalitis (temporal lobe periodic lateralized discharges - PLEDs)

5. Management

5A. Empiric Treatment - Start Without Delay

Do not wait for LP results or culture sensitivity before starting antibiotics in a critically ill patient.

Suspected Bacterial Meningitis:

DrugDosePurpose
Dexamethasone0.15 mg/kg IV q6h x4 daysAnti-inflammatory adjunct; MUST be given BEFORE or WITH first antibiotic dose - reduces mortality and neurologic sequelae, especially for S. pneumoniae
Ceftriaxone2 g IV q12hCovers S. pneumoniae, N. meningitidis, H. influenzae
Ampicillin2 g IV q4hAdd if age >50, immunocompromised, or alcoholic (Listeria coverage)
Vancomycin15-20 mg/kg IV q8-12hAdd if MRSA risk or ceftriaxone-resistant pneumococcus suspected

Suspected Viral Encephalitis (HSV):

  • Acyclovir 10 mg/kg IV every 8 hours - initiate empirically for all encephalitis cases until HSV excluded by CSF PCR
  • Acyclovir is also used for VZV encephalitis at 10-15 mg/kg IV q8h
  • CMV encephalitis: ganciclovir 5 mg/kg IV q12h (± foscarnet)
  • Arboviral encephalitis: no specific treatment; start empiric acyclovir pending CSF diagnosis

Suspected Cerebral Malaria:

  • IV artesunate (preferred) or IV quinine/quinidine
  • Concurrent empiric antibiotics for bacterial meningitis if CSF not yet available

Suspected Tuberculous Meningitis:

  • HRZE regimen (isoniazid, rifampicin, pyrazinamide, ethambutol) + dexamethasone

Suspected Fungal (Cryptococcal) Meningitis (HIV/Immunocompromised):

  • Amphotericin B (0.7-1 mg/kg/day) + flucytosine (25 mg/kg qid) x2 weeks induction
  • Serial therapeutic LPs for elevated ICP management

5B. Specific Condition Management

Heat Stroke:
  • Rapid external cooling (ice packs, misting fans, cooling blankets)
  • Target temperature <39°C within 30 minutes
  • Avoid antipyretics (they are ineffective for heat stroke)
NMS / Serotonin Syndrome:
  • Discontinue offending agent immediately
  • Aggressive cooling
  • Dantrolene (NMS), bromocriptine (NMS)
  • Benzodiazepines + cyproheptadine (serotonin syndrome)
Autoimmune Encephalitis:
  • First-line: IV methylprednisolone 1g/day x5 days ± IVIG or plasmapheresis
  • Second-line: rituximab, mycophenolate mofetil
Septic Encephalopathy:
  • Treat the underlying sepsis (source control, antibiotics, fluids, vasopressors per Surviving Sepsis guidelines)
  • Avoid unnecessary sedation; use light sedation protocols
  • Daily awakening trials
Seizure Management:
  • Benzodiazepines first-line (lorazepam or diazepam IV)
  • Levetiracetam, valproate, or fosphenytoin as second-line
  • Intubation + propofol/midazolam infusion for refractory status epilepticus

5C. Supportive Care (All Patients)

  • Head of bed at 30° (reduces ICP)
  • ICP management if cerebral edema: osmotherapy with mannitol (0.5-1 g/kg IV) or hypertonic saline 3%
  • Fluid management: avoid hypotonic fluids; maintain euvolemia
  • Glycemic control: target 140-180 mg/dL in ICU
  • Antipyretics (paracetamol/acetaminophen) for fever > 38.5°C - evidence shows fever worsens outcomes in acute brain injury (reducing neuronal metabolic demand)
  • DVT prophylaxis once LP completed
  • Nutrition: early enteral feeding
  • Foley catheter + monitoring of I/O

6. Clinical Decision Points Summary

Fever + Altered Sensorium
│
├─ IMMEDIATE: Stabilize ABC, glucose, blood cultures
│
├─ CT HEAD if: focal signs / papilledema / immunocompromised / new seizures
│
├─ LUMBAR PUNCTURE (as soon as safe)
│
├─ Empiric Rx before results:
│   ├─ Ceftriaxone + Vancomycin + Ampicillin (if Listeria risk) + Dexamethasone
│   ├─ Acyclovir (if encephalitis features)
│   ├─ Artesunate (if malaria risk)
│   └─ Thiamine (if alcoholism suspected)
│
├─ CSF results → tailor therapy
│
└─ ICU admission if: GCS ≤12, hemodynamic instability, seizures, rapid deterioration

7. Key Prognostic Factors

Poor outcome in bacterial meningitis is associated with (Harrison's Principles of Internal Medicine 22E):
  • Coma at presentation
  • Seizures
  • Hypotension
  • Purpuric rash
  • Pneumococcal etiology
  • CSF glucose <10 mg/dL, protein >2.5 g/L
  • Peripheral leukopenia or thrombocytopenia
For viral encephalitis, prognosis depends on causative virus, immune status, and speed of acyclovir initiation (HSV). Older and immunocompromised patients have worse outcomes.

References:
  • Plum and Posner's Diagnosis and Treatment of Stupor and Coma - Tables 1.1, 1.2; Chapter 1
  • Harrison's Principles of Internal Medicine 22E (2025, McGraw Hill) - Chapter on Neurologic Infections with or without Septic Shock
  • Tintinalli's Emergency Medicine: A Comprehensive Study - Chapters 162, 174 (Diseases with Fever and CNS Involvement; Encephalitis)
  • Miller's Anesthesia, 2-Volume Set, 10e - Encephalitis, Neuroanesthetic Management
  • Rosen's Emergency Medicine - Central Nervous System Infections
This is a shared conversation. Sign in to Orris to start your own chat.